abstract |
The present invention relates to novel sulphonamides of the general formula (I) (see formula I) in which the substituents R1, R2, R3, R4 and A and X are as defined above, and also to processes for their preparation and to their use as antiviral agents, in particular against cytomegaloviruses. |